J
Jun Shao
Researcher at Sichuan University
Publications - 38
Citations - 333
Jun Shao is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 7, co-authored 24 publications receiving 119 citations.
Papers
More filters
Journal ArticleDOI
Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer
TL;DR: In patients with resected stage I NSCLC, the older age, p-stage IB (versus IA), sublobar resection, histology subtype, and LVI were significantly associated with worse overall survival, and high architectural grade of LUAD, brain metastasis and bone metastasis were independent risk factors with PRS.
Journal ArticleDOI
The landscape of immune checkpoint inhibitor plus chemotherapy versus immunotherapy for advanced non‐small‐cell lung cancer: A systematic review and meta‐analysis
TL;DR: The comparative efficacy and safety of ICI‐chemotherapy versus ICi‐monotherapy in advanced NSCLC is estimated.
Journal ArticleDOI
Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer
TL;DR: The magnitude of survival benefit is sex‐dependent and male patients seemed to obtain more consistent and favorable outcomes from ICIs than women patients in NSCLC.
Journal ArticleDOI
Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer.
TL;DR: Compared with standard treatments, ICI drugs increased the risk of organ-specific IRAEs, although the overall incidence remained low, and ICI therapy was safer than chemotherapy, especially ICI monotherapy such as anti-PD-1 antibodies in NSCLC.
Journal ArticleDOI
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
Chengdi Wang,Qiuxiao Yu,Tingting Song,Zhoufeng Wang,Lujia Song,Ying Yang,Jun Shao,Jingwei Li,Yinyun Ni,Ningning Chao,Li Zhang,Weimin Li +11 more
TL;DR: In this article , the authors performed scRNA-seq on 72,475 immune cells from 40 samples of tumor and matched adjacent normal tissues spanning 19 NSCLC patients, and drew a systematic immune cell transcriptome atlas.